RAE1 and neoplasm: To confirm if DTIC can upregulate the NKG2D ligands (NKG2DL) on tumour cells, on day 18, the tumours from Fig. 6a were subject to the flow cytometric analysis for Rae-1 and Mult-1 NKG2DL.